Assembling a new generation of radiopharmaceuticals with supramolecular theranostics.
Autor: | Moreno-Alcántar G; Department of Chemistry, School of Natural Sciences, Technical University of Munich, Garching bei München, Germany., Drexler M; Department of Chemistry, School of Natural Sciences, Technical University of Munich, Garching bei München, Germany., Casini A; Department of Chemistry, School of Natural Sciences, Technical University of Munich, Garching bei München, Germany. angela.casini@tum.de.; Munich Data Science Institute (MDSI), Technical University of Munich, Garching bei München, Germany. angela.casini@tum.de. |
---|---|
Jazyk: | angličtina |
Zdroj: | Nature reviews. Chemistry [Nat Rev Chem] 2024 Dec; Vol. 8 (12), pp. 893-914. Date of Electronic Publication: 2024 Oct 28. |
DOI: | 10.1038/s41570-024-00657-4 |
Abstrakt: | Supramolecular chemistry has been used to tackle some of the major challenges in modern science, including cancer therapy and diagnosis. Supramolecular platforms provide synthetic flexibility, rapid generation through self-assembly, facile labelling, unique topologies, tunable reversibility of the enabling noncovalent interactions, and opportunities for host-guest chemistry and mechanical bonding. In this Review, we summarize recent advances in the design and radiopharmaceutical application of discrete self-assembled coordination complexes and mechanically interlocked molecules - namely, metallacages and rotaxanes, respectively - as well as in situ-forming supramolecular aggregates, specifically pinpointing their potential as next-generation radiotheranostic agents. The outlook of such supramolecular constructs for potential applications in the clinic is discussed. Competing Interests: Competing interests: The authors declare no competing interests. (© 2024. Springer Nature Limited.) |
Databáze: | MEDLINE |
Externí odkaz: |